Journal profile · Medicine-Psychiatry and Mental Health

Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring

ISSN 2352-8729 · Wiley-Blackwell · United States

Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring: CAS Zone 3 · Medicine (2025 upgraded edition); fully open access; APC about USD 2,670; median 119 days to acceptance (100 articles, last 24 months); 194 articles in 2025; indexed in Scopus.

Impact factor—No published value
CAS zoneZone 3 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 2 · Medicine
Review time119 daysMedian, submission to acceptance · 100 articles, last 24 months · Crossref
APCUSD 2,670Fully open access
Acceptance—No reports yet
Articles per year1942025 · OpenAlex count

Scope

Aims, scope and focus

Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring is published by Wiley-Blackwell and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments and Functional Brain Connectivity Studies, together about 64.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)

Research area (LetPub): Medicine-Psychiatry and Mental Health

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Dementia and Cognitive Impairment ResearchMedicine38.3%
  2. Alzheimer's disease research and treatmentsMedicine21.2%
  3. Functional Brain Connectivity StudiesNeuroscience4.9%
  4. Traumatic Brain Injury ResearchMedicine3.3%
  5. Intracerebral and Subarachnoid Hemorrhage ResearchMedicine2.8%
  6. Cancer-related cognitive impairment studiesMedicine2.4%
  7. Intensive Care Unit Cognitive DisordersMedicine2%
  8. Neurobiology of Language and BilingualismNeuroscience1.8%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
LevelCategoryZone
MajorMedicineZone 3
MinorClinical NeurologyZone 3
MinorNeurosciencesZone 3

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
LevelCategoryZone
MajorMedicineZone 2
MinorClinical NeurologyZone 2
MinorNeurosciencesZone 2

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

ScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

CiteScore 2026-06
7.1LetPub ·
SJR 2026-06
1.77LetPub ·
SNIP 2026-06
1.28LetPub ·
h-index
88OpenAlex ·
i10-index
754OpenAlex ·
2-year mean citedness
2.79OpenAlex ·
Share of gold OA articles
0%LetPub ·

Articles by year OpenAlex count · 1,524 in total · the current year is incomplete

YearArticlesOpen accessCitations
202624624684
2025194194541
20241681681,069
20231281281,962
20221241242,557
20211241243,332

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with Crossref · to

119 daysMedian, submission to acceptance · P25–P75 86 days – 181 days

Acceptance to online
median 37 days (100 articles)
Submission to online
median 165 days
Sample
100 articles with submission and acceptance dates (465 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
about 8 weeksLetPub ·
Submission to publication (journal-reported)
about 8 weeksDOAJ ·
Peer review
Single anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJUSD 2,670 / GBP 1,940 / EUR 2,180YesCC BY, CC BY-NC, CC BY-NC-ND
OpenAlexUSD 2,540 / EUR 2,080 / GBP 1,850——
LetPubUSD 2,310 / GBP 1,680 / EUR 1,890Yes—

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
Wiley-Blackwell
Country or region
United States
Language
English
ISSN
2352-8729
Official links

FAQ

Frequently asked questions about Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring

What CAS zone is Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring in?

In the 2025 upgraded edition of the CAS Journal Ranking, Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring is in Zone 3 of Medicine, and in Zone 3 of the minor category Clinical Neurology / Neurosciences. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

How long does peer review take at Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring?

Based on the dates recorded on 100 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 119 days (interquartile range 86–181 days); authors report an average review time of about 8 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring?

According to LetPub and DOAJ records, Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring is indexed in Scopus and DOAJ.

Is Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring open access, and what is the APC?

Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring is a fully open-access journal. APC about USD 2,670.

Sources and updates

The facts on this page come from LetPub, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .